Related Experiment Video

Updated: Aug 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

The MDM2-p53 interaction

Ute M Moll1, Oleksi Petrenko

  • 1Department of Pathology, State University of New York at Stony Brook, Stony Brook, NY 11794-8691, USA. umoll@notes.cc.sunysb.edu

Molecular Cancer Research : MCR
|January 7, 2004
PubMed

Insights

The p53 protein guards against damaged cells, but MDM2 inhibits its function. Disrupting the p53-MDM2 interaction is a key strategy for activating p53 and developing new cancer therapies.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • The p53 protein is a crucial tumor suppressor that halts the proliferation of cells with DNA damage.
  • MDM2 acts as the primary antagonist to p53, ubiquitinating and degrading it in unstressed cells.
  • The p53-MDM2 interaction is a tightly regulated, conformation-based process essential for cellular homeostasis.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the p53-MDM2 interaction.
  • To explore the potential of targeting the p53-MDM2 complex for cancer therapy.
  • To understand how disrupting this interaction leads to p53 activation.

Main Methods:

  • Structural and functional analysis of the p53-MDM2 complex.
  • Biochemical assays to study protein-protein interactions.
  • Development and testing of small molecules designed to disrupt the p53-MDM2 binding.

Main Results:

  • The p53-MDM2 interaction is conformation-dependent and regulated at multiple levels.
  • Disruption of the p53-MDM2 complex is a critical event for p53 activation.
  • Small lipophilic molecules capable of disrupting the p53-MDM2 interaction have been designed.

Conclusions:

  • The p53-MDM2 interaction is a validated target for cancer therapeutics.
  • Targeting this interaction can lead to the induction of p53 and its tumor-suppressive functions.
  • Further development of small molecules disrupting p53-MDM2 binding holds promise for novel cancer treatments.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...